After 25 minutes of trading, the OMXS30 index was up 0.13 percent to 2,816.62. During the day, the index has moved within a range of 0.13 percent at its lowest and 0.32 percent at its highest.
The broad OMXSPI was up 0.02 percent.
In the news flow, fertility company Vitrolife is taking a goodwill write-down of SEK 5.4 billion in connection with the acquisition of Igenomix. The company is also implementing a restructuring in which 6 percent of the workforce will be laid off. This will result in one-time costs of SEK 55 million, which will generate annual savings of SEK 65 million.
Cybersecurity company Yubico has had a difficult year, and CEO Mattias Danielsson is now stepping down. Chief Operating Officer Jerrod Chong will take over as acting CEO. Furthermore, Hansa Biopharma is falling after negative study results.
| Companies | Change | Comment |
| AQ Group | 2.7 | SEB raises to buy (hold), target price SEK 206 (195) |
| Coffee Stain | 2.6 | SEB and SB1 Markets initiate coverage with a buy recommendation, Nordea initiates with hold |
| Embracer | 2 | Nordea resumes coverage with a buy recommendation and a target price of SEK 80 |
| Bravida | 1 | Signs framework agreement in Denmark worth DKK 300 million |
| Yubico | - | CEO Mattias Danielson resigns, COO Jerrod Chong becomes acting CEO |
| SKF | - | JP Morgan puts the stock on negative catalyst watch |
| Vitrolife | - | Takes goodwill write-down of SEK 5.4 billion, cost-cutting program where 6 percent of staff will be laid off |
| Rejlers | - | Handelsbanken downgrades to hold (buy), target price SEK 215 (229) |
| Hansa Biopharma | - | Did not achieve primary efficacy endpoint in phase 3 study for anti-GBM |
